Solos Endoscopy has announced the completion of a capital restructuring initiative, part of a previously announced recapitalization plan expected to help grow the company over the next 12 months, according to a company news release.
The restructuring involved a common stock consolidation that took effect Nov. 24, 2010. The stock symbol for Solos will be changed temporarily to SNDYD for a period of 20 business days following the consolidation.
The plan will allow Solos greater flexibility to use the assets of the company for corporate purposes, including raising capital, acquisitions or employee compensation.
Read the Solos Endoscopy news release on capital restructuring.
Read more on GI and endoscopy:
-4 Steps to Increase Screening Colonoscopy Cases
-Researchers Revisit Surveillance Colonoscopy Utilization
The restructuring involved a common stock consolidation that took effect Nov. 24, 2010. The stock symbol for Solos will be changed temporarily to SNDYD for a period of 20 business days following the consolidation.
The plan will allow Solos greater flexibility to use the assets of the company for corporate purposes, including raising capital, acquisitions or employee compensation.
Read the Solos Endoscopy news release on capital restructuring.
Read more on GI and endoscopy:
-4 Steps to Increase Screening Colonoscopy Cases
-Researchers Revisit Surveillance Colonoscopy Utilization